Liu Joy Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$1.62M

Insider Activity of Liu Joy

According to the SEC Form 4 filings, Liu Joy, being in a position of

  1. EVP and Chief Legal Officer at Vertex Pharmaceuticals Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 3802 shares for $1.77M,
    over all time since 2021-03-05, has bought 0 shares, and sold 10792 shares for $3.39M.

Biography of Liu Joy

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$1,767,1514100

Comparison of Insiders on Amount of Buys and Sells

2026-07-01SaleVertex Pharmaceuticals Incorporated
VRTX
EVP and Chief Legal Officer
828
0.0003%
$502.71$416,244+3.41%
2026-05-01SaleVertex Pharmaceuticals Incorporated
VRTX
EVP and Chief Legal Officer
1,104
0.0004%
$425.02$469,222+17.58%
2026-04-01SaleVertex Pharmaceuticals Incorporated
VRTX
EVP and Chief Legal Officer
978
0.0004%
$449.17$439,288+8.49%
2026-03-02SaleVertex Pharmaceuticals Incorporated
VRTX
EVP and Chief Legal Officer
892
0.0004%
$495.96$442,396-1.45%
2022-08-15SaleVertex Pharmaceuticals Incorporated
VRTX
SVP, General Counsel
698
0.0003%
$301.63$210,538+2.06%
2022-08-10SaleVertex Pharmaceuticals Incorporated
VRTX
SVP, General Counsel
36
<0.0001%
$300.32$10,812+5.21%
2022-08-09SaleVertex Pharmaceuticals Incorporated
VRTX
SVP, General Counsel
946
0.0004%
$300.00$283,800+4.08%
2022-05-16SaleVertex Pharmaceuticals Incorporated
VRTX
SVP, General Counsel
35
<0.0001%
$254.36$8,903+15.78%
2022-04-29SaleVertex Pharmaceuticals Incorporated
VRTX
SVP, General Counsel
22
<0.0001%
$276.72$6,088+7.25%
2021-05-17SaleVertex Pharmaceuticals Incorporated
VRTX
SVP, General Counsel
112
<0.0001%
$216.34$24,230-4.41%
2021-03-05SaleVertex Pharmaceuticals Incorporated
VRTX
SVP, General Counsel
5,141
0.002%
$209.69$1.08M-2.49%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.